Healthcare

The InForm device is being used within ACL's flagship anatomical pathology laboratory in Western Australia to perform real-time, slide-free cellular imaging at the point of contact. As at the date of the announcement, 84 cases had been imaged, spanning tissue samples across multiple systems …

• A limited on-market share buyback of up to 3.5 million shares over 12 months was approved on 31 July 2026.

• The FDA issued a Not Substantially Equivalent (NSE) determination for EchoSolv HF's initial 510(k) application.

Sonic operates across nine countries and 11 markets and provides medical services to more than 140 million patients each year. Its model is built around laboratory medicine, scale efficiencies and local clinical brands, giving the group a broad geographic footprint rather than reliance on …

Cochlear Limited (ASX:COH) remains a closely followed healthcare technology company, with its investment story shaped by implant adoption, product innovation and the pace at which new systems translate into procedure and services growth. At A$135.31 on 9 September 2026, the share price keeps attention …

Ansell (ASX:ANN) occupies a distinctive position within healthcare because its earnings are linked to both medical demand and industrial safety spending. The company supplies protective products across healthcare, life sciences,Manufacturingand other workplaces, giving investors exposure to a diversified safety-solutions model. Ansell shares were priced …

TELIX operates across precision medicine, therapeutics and manufacturing. Its approved prostate-cancer imaging products Illuccix and Gozellix form the core of the commercial business, while Telix Manufacturing Solutions is expanding internal and third-party radiopharmaceutical capabilities. This structure gives the company exposure to both recurring diagnosticDemandand …